Date of publication: September 2016
Publication type: Journal article
In a nutshell: “Many drugs that have been approved by the Food and Drug Administration could be repurposed or used off label to treat Alzheimer’s disease, according to reports from the Alzheimer’s Drug Discovery Foundation conference in New Jersey.
The foundation is supporting 18 approved drugs in repurposing trials. This brings the total number of approved drugs that were being studied for use in treating Alzheimer’s disease in repurposing trials to at least 127, the foundation said.”
Length of publication: 1 page
Some important notes: This article is available in full text to all NHS Staff using Athens, for more information about accessing full text follow this link to find your local NHS Library